Browsing by Contributors Arriva Pharmaceuticals Inc

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 1 of 1
PreviewIssue DateTitleContributor(s)
3-Jun-2016Modeling in vivo interactions of engineered nanoparticles in the pulmonary alveolar lining fluidAsthma UK; Asthma UK; GlaxoSmithKline Services Unlimited; Department of Health; Imperial College Trust; Wellcome Trust; Imperial College Trust; Imperial College Trust; Asthma UK; Byk Gulden; GlaxoSmithKline Services Unlimited; Scios Inc; Novartis Pharmaceuticals UK Limited; Novartis Pharmaceuticals UK Limited; Novartis Pharmaceuticals UK Limited; Asthmatx, Inc; National Institutes of Health; University of Medicine and Dentistry of New Jersey/School of Public Health; Arriva Pharmaceuticals Inc; Department of Health; Baxter Healthcare SA; Syngenta Crop Protection AG; Unilever UK Central Resources Ltd; Royal Brompton & Harefield Hospital Charitable Fund; Colt Foundation; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering & Physical Science Research Council (EPSRC); Imperial College Trust; Medical Research Council (MRC); Commission of the European Communities; Imperial College Trust; Wellcome Trust; Natural Environment Research Council (NERC); Pfizer Limited; Novartis Pharmaceuticals UK Limited; Unilever UK Central Resources Ltd; Natural History Museum; Wellcome Trust; Engineering & Physical Science Research Council (EPSRC); Imperial College Trust; Kaust UK Ltd; Asthma UK; Department for Environment, Food and Rural Affairs; Medical Research Council (MRC); Medical Research Council (MRC); Imperial College Trust; Commission of the European Communities; Novartis Pharma Ag; AstraZeneca UK Limited; FEI Company; The Royal Society; Royal Brompton & Harefield NHS Foundation Trust; Engineering & Physical Science Research Council (EPSRC); National Institute for Health Research; Royal Brompton & Harefield NHS Foundation Trust; British Heart Foundation; Kaust UK Ltd; Commission of the European Communities; The Leverhulme Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council (MRC); Commission of the European Communities; Commission of the European Communities; Asthma UK; Engineering & Physical Science Research Council (EPSRC); Royal Brompton & Harefield NHS Foundation Trust; UCB Celltech Ltd; Engineering & Physical Science Research Council (EPSRC); Medical Research Council (MRC); BP International Limited; Kaust; Technology Strategy Board; Merck Sharp & Dohme Ltd.; Commission of the European Communities; British Heart Foundation; Commission of the European Communities; British Lung Foundation; Wellcome Trust; Dunhill Medical Trust; Commission of the European Communities; Wellcome Trust; Vectura Limited; Shell Global Solutions International BV; Imperial College Trust; National Institute for Health Research